Meftal is one of the most commonly used painkillers
New Delhi:
The Indian Pharmacy Council (IPC) has issued a drug safety alert advising healthcare professionals and patients to monitor the side effects of meftal, a painkiller commonly used to treat menstrual pain and rheumatoid arthritis.
Mefenamic acid painkillers are prescribed to treat rheumatoid arthritis, osteoarthritis, dysmenorrhea, mild to moderate pain, inflammation, fever, and tooth pain.
The committee said in its alert that preliminary analysis of adverse drug reactions from the Pharmacovigilance Program of India (PvPI) database revealed drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome. Stated.
“Healthcare professionals and patients/consumers are advised to closely monitor the potential for the above-mentioned adverse drug reactions (ADRs) associated with the use of the suspected drug,” according to the alert issued on November 30. About.
In case of encountering such reactions, people can submit their concerns to the National Coordination Center for PvPI under the Commission by submitting a form on the website (www.ipc.gov.in) or through the Android mobile app ADR PvPI. The alert warns that you should report. PvPI helpline number 1800-180-3024.
The IPC, an autonomous body under the Ministry of Health, sets standards for all medicines manufactured, sold and consumed in India.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
